ArticlePloS one2019

Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug.

D Perlstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.